References
- Hadlock TA, Kim J, Deschler DG. The effect of subcutaneously administered low-molecular-weight heparin on microarterial thrombosis in the rat. Arch Facial Plast Surg. 2003;5(1):36–39.
- Lee KS, Suh JD, Han SB, et al. The effect of aspirin and prostaglandin E(1) on the patency of microvascular anastomosis in the rats. Hand Surg. 2001;6(2):177–185.
- Akan M, Karanfil H, Çakır B, et al. Ratlarda Clopidogrel’in Mikrovasküler Anastomozlarda Akım Üzerine Etkisi. Turk Plast Surg. 2008;16:42–46.
- Wilmington D. Astra-Zeneca; Brilinta (ticagrelor) Tablets, prescribing information. July 2011; [cited 2012 Feb 28]. Available from: www1.astrazenecaus.com/pi/brilinta.pdf.
- Abergel E, Nikolsky E. Ticagrelor: an investigational oral antiplatelet treatment for reduction of major adverse cardiac events in patients with acute coronary syndrome. Vasc Health Risk Manag. 2010;6:963–977.
- Stepnick D, Hayden R, Hogikyan N. Development of thrombosis models in the rabbit. Arch Otolaryngol Head Neck Surg. 1994;120(9):997–1002.
- Moore MG, Deschler DG. Clopidogrel (Plavix) reduces the rate of thrombosis in the rat tuck model for microvenous anastomosis. Otolaryngol Head Neck Surg. 2007;136(4):573–576.
- Hamilton RB, O’Brien BM, Morrison A, et al. Survival factors in replantation and revascularization of the amputated thumb-10 years experience. Scand J Plast Reconstr Surg. 1984;18(2):163–173.
- Lighthall JG, Cain R, Ghanem TA, et al. Effect of postoperative aspirin on outcomes in microvascular free tissue transfer surgery. Otolaryngol Head Neck Surg. 2013;148(1):40–46.
- Adams WP, Ansari MS, Hay MT, et al. Patency of different arterial and venous end-to-side microanastomosis techniques in a rat model. Plast Reconstr Surg. 2000;105:61–156.
- Schubert HM, Hohlrieder M, Falkensammer P, et al. Bipolar anastomosis technique (BAT) enables “fast-to-do”, high-quality venous end-to-end anastomosis in a new vascular model. J Craniofac Surg. 2006;17:768–772.
- Wilson NV, Salisbury JR, Kakkar VV. Effect of low molecular weight heparin on intimal hyperplasia. Br J Surg. 1991;78(11):1381–1383.
- Fuller R, Chavez BPT. Ticagrelor (brilinta), an antiplatelet drug for acute coronary syndrome. Pt. 2012;37:562–568.
- Dhiwakar M, Khan NA, McClymont LG. Surgical resection of cutaneous head and neck lesions: does aspirin use increase hemorrhagic risk? Arch Otolaryngol Head Neck Surg. 2006;132(11):1237–1241.
- Kroll SS, Miller MJ, Reece GP, et al. Anticoagulants and hematomas in free flap surgery. Plast Reconstr Surg. 1995;96(3):643–647.
- Gurbel PA, Bliden KP, Butler K, et al. Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation. 2009;120(25):2577–2525.
- Weisshaar S, Litschauer B, Eipeldauer M, et al. Ticagrelor mitigates ischaemia-reperfusion induced vascular endothelial dysfunction in healthy young males – a randomized, single-blinded study. Br J Clin Pharmacol. 2017;83(12):2651–2660.
- Husted S, Emanuelsson H, Heptinstall S, et al. Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin. Eur Heart J. 2006;27(9):1038–1047.
- Emerick KS, Deschler DG. The effect of low-molecular-weight heparin on microvenous thrombosis in a rat model. Arch Facial Plast Surg. 2007;9(1):19–21.
- Nayak VK, Deschler DG. Clopidogrel use for reducing the rate of thrombosis in a rat model of microarterial anastomosis. Arch Otolaryngol Head Neck Surg. 2005;131(9):800–803.
- Hérault J-P, Dol F, Gaich C, et al. Effect of clopidogrel on thrombin generation in platelet-rich plasma in the rat. Thromb Haemost. 1999;81(06):957–960.
- Birkeland K, Parra D, Rosenstein R. Antiplatelet therapy in acute coronary syndromes: focus on ticagrelor. J Blood Med. 2010;1:197–219.
- Aydoğdu S, Çelebi ÖÖ. The use of ticagrelor in acute coronary syndrome. Arch Turk Soc Cardiol. 2013;41 (Suppl 1):12–16.
- Kyle D, Morrison C. Ticagrelor for neuroendovascular procedures: a case series. J Pharm Pract. 2018;31(1):115–119.
- Solo K, Lavi S, Kabali C, et al. Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis. BMJ. 2019;367:l5476.
- Capodanno D, Angiolillo DJ. Management of antiplatelet therapy in patients with coronary artery disease requiring cardiac and noncardiac surgery. Circulation. 2013;128(25):2785–2798.